This inventor holds 2 USPTO granted patents. Top assignee: Chiron Corporation. Active years: 1998-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-1999
Title: The Innovative Contributions of Ronald N Zuckerman
Introduction
Ronald N Zuckerman is a notable inventor based in Berkeley, CA. He has made significant contributions to the field of synthetic chemistry, particularly in the development of N-substituted oligomers. His work has implications for therapeutic applications, showcasing the potential of synthetic compounds in medicine.
Latest Patents
Zuckerman holds 2 patents related to the synthesis of N-substituted oligomers. His latest patent describes a solid-phase method for synthesizing poly (N-substituted glycines), also known as poly NSGs. This innovative approach allows for the assembly of oligomers with diverse side-chain substituents, which can be utilized in the generation and rapid screening of peptidomimetic libraries. The method involves a two-step cycle of acylation and nucleophilic displacement, enabling the efficient synthesis of these biologically active compounds.
Career Highlights
Zuckerman has been associated with Chiron Corporation, where he has contributed to advancements in synthetic methodologies. His research focuses on creating peptide-like compounds that are not found in nature but are synthetically accessible. These compounds have demonstrated significant biological activity and proteolytic stability, marking a notable achievement in the field.
Collaborations
Throughout his career, Zuckerman has collaborated with esteemed colleagues, including Janice M Kerr and Stephen B Kent. These collaborations have further enriched his research and contributed to the development of innovative synthetic techniques.
Conclusion
Ronald N Zuckerman's work in the synthesis of N-substituted oligomers represents a significant advancement in synthetic chemistry. His contributions have the potential to impact therapeutic development and expand the possibilities of synthetic compounds in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
